Liesbeth Delesie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Liesbeth Delesie has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Els Tobback
Department of General Internal Medicine, University Hospital Ghent, Gent, Belgium
4 shared publications - An Mariman
Department of General Internal Medicine, Infectious Diseases and Psychosomatic Medicine, University Hospital Ghent, Belgium
3 shared publications - Dirk Vogelaers
AZ Delta
3 shared publications Els Tobback
HIV Cure Research Center, Department of Internal Medicine and Pediatrics, Ghent University, 9000 Ghent, Belgium
3 shared publications- Ignace Hanoulle
Department of General Internal Medicine, Ghent University Hospital, De Pintelaan 185, B - 9000 Ghent, Belgium
3 shared publications - Dirk Pevernagie
Department of Internal Medicine and Pediatrics Ghent University Ghent Belgium
2 shared publications
Latest Publications
- 23 October 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 16 (770) , eadn2364
Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa
To prevent infection by respiratory viruses and consequently limit virus circulation, vaccines need to promote mucosal immunity. The extent to which the currently used messenger RNA (mRNA)–based COVID-19 vaccines induce mucosal immunity remains poorly characterized. We evaluated mucosal neutralizing antibody responses in a cohort of 183 individuals. Participants were sampled at several time points after primary adenovirus vector–based or mRNA-based COVID-19 vaccination and after mRNA-based booster vaccinations. Our findings revealed that repeated vaccination with mRNA boosters promoted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibodies in nasal secretions. Nasal and serum neutralizing antibody titers of both IgG and IgA isotypes correlated to one another. We investigated the source of these mucosal antibodies in a mouse model wherein mice received repeated mRNA vaccines for SARS-CoV-2. These experiments indicated that neutralizing antibody–producing cells reside in the spleen and bone marrow, whereas no proof of tissue homing to the respiratory mucosa was observed, despite the detection of mucosal antibodies. Serum transfer experiments confirmed that circulating antibodies were able to migrate to the respiratory mucosa. Collectively, these results demonstrate that, especially upon repeated vaccination, the currently used COVID-19 mRNA vaccines can elicit mucosal neutralizing antibodies and that vaccination might also stimulate mucosal immunity induced by previous SARS-CoV-2 infection. Moreover, migration of circulating antibodies to the respiratory mucosa might be a main mechanism. These findings advance our understanding of mRNA vaccine–induced immunity and have implications for the design of vaccine strategies to combat respiratory infections.
- 23 October 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 16 (770) , eadn2364
Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa
To prevent infection by respiratory viruses and consequently limit virus circulation, vaccines need to promote mucosal immunity. The extent to which the currently used messenger RNA (mRNA)–based COVID-19 vaccines induce mucosal immunity remains poorly characterized. We evaluated mucosal neutralizing antibody responses in a cohort of 183 individuals. Participants were sampled at several time points after primary adenovirus vector–based or mRNA-based COVID-19 vaccination and after mRNA-based booster vaccinations. Our findings revealed that repeated vaccination with mRNA boosters promoted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibodies in nasal secretions. Nasal and serum neutralizing antibody titers of both IgG and IgA isotypes correlated to one another. We investigated the source of these mucosal antibodies in a mouse model wherein mice received repeated mRNA vaccines for SARS-CoV-2. These experiments indicated that neutralizing antibody–producing cells reside in the spleen and bone marrow, whereas no proof of tissue homing to the respiratory mucosa was observed, despite the detection of mucosal antibodies. Serum transfer experiments confirmed that circulating antibodies were able to migrate to the respiratory mucosa. Collectively, these results demonstrate that, especially upon repeated vaccination, the currently used COVID-19 mRNA vaccines can elicit mucosal neutralizing antibodies and that vaccination might also stimulate mucosal immunity induced by previous SARS-CoV-2 infection. Moreover, migration of circulating antibodies to the respiratory mucosa might be a main mechanism. These findings advance our understanding of mRNA vaccine–induced immunity and have implications for the design of vaccine strategies to combat respiratory infections.
- Open Access
- 5 July 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 122, 628-635
Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial
- 5 July 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 122, 628-635
Open AccessEfficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial
- 1 December 2018
- Published by Elsevier in Intensive and Critical Care Nursing
- Vol. 49, 79-80
Effectiveness of institutional policies, protocols and order sets on organ donation rates in the Intensive Care Unit
- 1 December 2018
- Published by Elsevier in Intensive and Critical Care Nursing
- Vol. 49, 79-80
Effectiveness of institutional policies, protocols and order sets on organ donation rates in the Intensive Care Unit
- 18 January 2017
- Published by Wiley in Journal of Advanced Nursing
- Vol. 73 (7) , 1610-1619
Exploring the potential role of the advanced nurse practitioner within a care path for patients with chronic fatigue syndrome
Aims: To explore the experiences and expectations of patients with chronic fatigue syndrome and general practitioners to develop the potential role of an advanced nurse practitioner at the diagnostic care path of abnormal fatigue developed for regional transmural implementation in the Belgian provinces of East and West Flanders.Background: Patients with chronic fatigue syndrome experience an incapacitating chronic fatigue that is present for at least 6 months. Since many uncertainties exist about the causes and progression of the disease, patients have to cope with disbelief and scepticism. Access to health care may be hampered, which could lead to inappropriate treatments and guidance.Design: Qualitative design.Methods: Individual semi‐structured interviews were conducted with patients with chronic fatigue syndrome and general practitioners in Belgium. Data were collected over 9 months in 2014‐2015. All interviews were audio recorded and transcribed for qualitative analysis using open explorative thematic coding.Results: Fifteen patients and 15 general practitioners were interviewed. Three themes were identified: mixed feelings with the diagnosis, lack of one central intermediator and insufficient coordination. Participants stressed the need for education, knowledge and an intermediator to provide relevant information at the right time and to build up a trust relationship.Conclusion: This qualitative exploration underscores some clear deficiencies in the guidance of patients suffering from chronic fatigue syndrome and abnormal fatigue. An advanced nurse practitioner as a central intermediator in the transmural care of these patients could promote interdisciplinary/multidisciplinary collaboration and effective communication, provide education and ensure a structured and coordinated approach.
- 18 January 2017
- Published by Wiley in Journal of Advanced Nursing
- Vol. 73 (7) , 1610-1619
Exploring the potential role of the advanced nurse practitioner within a care path for patients with chronic fatigue syndrome
Aims: To explore the experiences and expectations of patients with chronic fatigue syndrome and general practitioners to develop the potential role of an advanced nurse practitioner at the diagnostic care path of abnormal fatigue developed for regional transmural implementation in the Belgian provinces of East and West Flanders.Background: Patients with chronic fatigue syndrome experience an incapacitating chronic fatigue that is present for at least 6 months. Since many uncertainties exist about the causes and progression of the disease, patients have to cope with disbelief and scepticism. Access to health care may be hampered, which could lead to inappropriate treatments and guidance.Design: Qualitative design.Methods: Individual semi‐structured interviews were conducted with patients with chronic fatigue syndrome and general practitioners in Belgium. Data were collected over 9 months in 2014‐2015. All interviews were audio recorded and transcribed for qualitative analysis using open explorative thematic coding.Results: Fifteen patients and 15 general practitioners were interviewed. Three themes were identified: mixed feelings with the diagnosis, lack of one central intermediator and insufficient coordination. Participants stressed the need for education, knowledge and an intermediator to provide relevant information at the right time and to build up a trust relationship.Conclusion: This qualitative exploration underscores some clear deficiencies in the guidance of patients suffering from chronic fatigue syndrome and abnormal fatigue. An advanced nurse practitioner as a central intermediator in the transmural care of these patients could promote interdisciplinary/multidisciplinary collaboration and effective communication, provide education and ensure a structured and coordinated approach.
- 3 February 2016
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 71 (5) , 1-6
Factors determining fatigue in the chronic fatigue syndrome: a path analysis
To explore the interrelationship of different dimensions (fatigue, neuroticism, sleep quality, global mental and physical health) in patients with chronic fatigue syndrome (CFS).
- 3 February 2016
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 71 (5) , 1-6
Factors determining fatigue in the chronic fatigue syndrome: a path analysis
To explore the interrelationship of different dimensions (fatigue, neuroticism, sleep quality, global mental and physical health) in patients with chronic fatigue syndrome (CFS).
- 16 November 2015
- Published by Taylor & Francis in Fatigue: Biomedicine, Health & Behavior
- Vol. 4 (2) , 94-103
Polysomnographic and multiple sleep latency testing data in a large sample of patients with chronic fatigue syndrome and their relationship with subjective scores
Background: Despite the majority of patients with chronic fatigue syndrome (CFS) complaining about sleep disturbances and/or non-refreshing sleep, abnormalities in objective sleep parameters have not consistently been identified in this population. Purpose: To assess objective parameters of sleep and sleepiness in a large sample of patients with CFS and their relationship with the subjective dimensions of mental and physical health, sleep quality, daytime sleepiness and fatigue. Methods: Objective sleep parameters were derived from polysomnography (PSG) and multiple sleep latency testing (MSLT). Subjective scores for mental and physical health, sleep quality, daytime sleepiness and fatigue were based on validated, self-report questionnaires. Hierarchical multiple regression analysis was performed to predict sleepiness, global quality of sleep and fatigue. Results: PSG in 184 CFS patients indicated decreased total sleep time and sleep efficiency as well as increased sleep latency and waking after sleep onset. Only a few modest but significant correlations (r’s < .30) were found between objective parameters of sleep and sleepiness and subjective scores for health, sleep quality and fatigue. Conclusions: Objective sleep parameters indicated poor sleep in CFS, suggesting an insomnia phenotype, but with only modest associations to subjective scores of mental and physical health, sleep quality, daytime sleepiness and fatigue.
- 16 November 2015
- Published by Taylor & Francis in Fatigue: Biomedicine, Health & Behavior
- Vol. 4 (2) , 94-103
Polysomnographic and multiple sleep latency testing data in a large sample of patients with chronic fatigue syndrome and their relationship with subjective scores
Background: Despite the majority of patients with chronic fatigue syndrome (CFS) complaining about sleep disturbances and/or non-refreshing sleep, abnormalities in objective sleep parameters have not consistently been identified in this population. Purpose: To assess objective parameters of sleep and sleepiness in a large sample of patients with CFS and their relationship with the subjective dimensions of mental and physical health, sleep quality, daytime sleepiness and fatigue. Methods: Objective sleep parameters were derived from polysomnography (PSG) and multiple sleep latency testing (MSLT). Subjective scores for mental and physical health, sleep quality, daytime sleepiness and fatigue were based on validated, self-report questionnaires. Hierarchical multiple regression analysis was performed to predict sleepiness, global quality of sleep and fatigue. Results: PSG in 184 CFS patients indicated decreased total sleep time and sleep efficiency as well as increased sleep latency and waking after sleep onset. Only a few modest but significant correlations (r’s < .30) were found between objective parameters of sleep and sleepiness and subjective scores for health, sleep quality and fatigue. Conclusions: Objective sleep parameters indicated poor sleep in CFS, suggesting an insomnia phenotype, but with only modest associations to subjective scores of mental and physical health, sleep quality, daytime sleepiness and fatigue.
- Open Access
- 1 November 2013
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 75 (5) , 491-496
Undiagnosed and comorbid disorders in patients with presumed chronic fatigue syndrome
- 1 November 2013
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 75 (5) , 491-496
Open AccessUndiagnosed and comorbid disorders in patients with presumed chronic fatigue syndrome